Health, according to the World Health Organization, is “a state of complete physical, mental and social well-being and not merely the absence of disease and infirmity”. A variety of definitions have been used for different purposes over time. Health can be promoted by encouraging healthful activities, such as regular physical exercise and adequate sleep, and by reducing or avoiding unhealthful activities or situations, such as smoking or excessive stress. Some factors affecting health are due to individual choices, such as whether to engage in a high-risk behavior, while others are due to structural causes, such as whether the society is arranged in a way that makes it easier or harder for people to get necessary healthcare services. Still other factors are beyond both individual and group choices, such as genetic disorders.
Now Read Carefully details
As per reports, Covid-19 patients with high blood sugar levels and those on steroids for prolonged periods, are said to be at high risk of getting affected by black fungus.
As Omicron cases surge across India, return of mucormycosis or black fungus is being dreaded by many. Last year, during the second wave, the rare yet lethal fungal infection caused by a group of mold called Mucormycete led to many fatalities in post Covid patients.
Mucormycosis can cause blindness, organ dysfunction, loss of body tissue, and even death if not treated on time. It can affect areas from where it can be inhaled – nose, sinus or lung.
Covid patients with high blood sugar levels and those on steroids for prolonged periods are said to be at high risk of getting affected by black fungus. Also, patients with immune-compromised systems or those who have undergone transplants or people who are on immunosuppressants or on a ventilator for a long period of time are at risk.
Nasal blockage or congestion, nasal discharge (blackish/ bloody, local pain on the cheekbone, one-sided facial pain, numbness or swelling, blackish discoloration over the bridge of nose, loosening of teeth, blurred or double vision with pain, thrombosis, necrosis, skin lesion, chest pain, pleural effusion, worsening of respiratory symptoms are some of the other symptoms of black fungus.
Mumbai registered its first case of mucormycosis recently where a 70-year-old Covid patient who tested positive on Jan 5 started showing symptoms of black fungus on January 12. Thereafter, he was admitted to the Wockhardt Hospital in Mumbai Central, where he is currently undergoing treatment.
“The patient had got admitted to the hospital on Jan 12 with the complaint of weakness and during the admission the sugar levels went upto 532. He was immediately put on to diabetic ketoacidosis treatment. The family said that from past 10 days the patient was not taking the diabetes medicines. On third day the patient complained of cheek pain and there was a swelling on left side of the face which made us suspicious about mucormycosis. On further investigation it revealed the growth of fungal hyphae. Patient underwent debridement surgery and the tissue was sent for investigations. The patient is stable now and currently on intravenous anti-fungals. He will undergo multiple check surgeries in future too,” said Dr Honey Savla, Internal Medicine, Wockhardt Hospital, Mumbai Central.
While mucormycosis cases are currently not being reported widely, we asked experts if there was a possibility of this deadly post-Covid disease making a comeback and wreaking havoc like last year.
“We know from the second wave that the risk factors for mucormycosis are prolonged hospitalizations, need of prolonged corticosteroids in those with moderate to severe covid and indiscriminate use of steroids in those with mild Covid. Though it is still too early to know if we will see large number of mucormycosis patients in the third wave, we expect it to be much lower because all the above risk factors are much lower with Omicron. Responsible use of steroids, antibiotics and good sugar control in those with diabetes is going to be key in averting this deadly disease going forward,” says Dr Trupti Gilada, Infectious Disease specialist, Masina Hospital, Mumbai.
“No, there is no rise in the cases of mucormycosis among patients suffering from Omicron. Since most of the patients have mild to moderate symptoms and do not require immunomodulators such as steroids or high flow oxygen support during their treatment, the incidence is low,” Dr Charu Dutt Arora Consultant Physician and Infectious Disease Specialist Head, Ameri Health, Asian Hospital, Faridabad.
Disclaimer Of https://thewomeninterest.com/
It must be agreed that the use of https://thewomeninterest.com/ website shall be at the user’s sole risk. To the maximum extent permitted by law, https://thewomeninterest.com/, its directors, employees, and agents will make no representations about the exactness of the website’s content or the content of any sites linked to the website of. https://thewomeninterest.com/ assumes:
no liability or responsibility for any errors, or inaccuracies,
personal injury or any damage to property resulting from the user’s access to and use of the website,
any interruption or cessation of transmission in relation to our website,
any bugs, Trojan horses, or viruses, which may be transmitted through the website or by any third party
any omissions or errors in content by way of content posted, transmitted, or emailed.
https://thewomeninterest.com/ does not guarantee, endorse, or assume responsibility for any product or service offered by a third party through the https://thewomeninterest.com/ website or any hyperlinked website or other advertising, and https://thewomeninterest.com/ will not be in any way be responsible for monitoring any transaction between the user and the third-party providers of services or products. The user should use his/her best judgment and exercise caution where appropriate. https://thewomeninterest.com/’s website may include hyperlinks to other websites owned or operated by parties other than us. https://thewomeninterest.com/ will not be held responsible for the exactness or availability of such other websites. Any inclusion of the hyperlink does not refer to any endorsement or recommendation of the content on such third-party websites.
It is reiterated that not all treatments that appear here at https://thewomeninterest.com/ website have been proven on a scientific basis. The information available on this site should in no way replace the advice of a doctor. https://thewomeninterest.com/ does not assume responsibility for the accuracy of the information provided here.
Please check with a professional or doctor before using any of the suggestions mentioned. https://thewomeninterest.com/ respects the intellectual property of others, and we request our users to do the same. https://thewomeninterest.com/ bears no responsibility for the content on other websites that the user may find while using Thewomeninterest.com products or services.